Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,500 | 141 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $369.77 | 19 | $0 (2024) |
| ABBVIE INC. | $264.85 | 11 | $0 (2024) |
| Novo Nordisk Inc | $262.04 | 18 | $0 (2024) |
| PFIZER INC. | $235.19 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $191.84 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $138.08 | 8 | $0 (2021) |
| Amarin Pharma Inc. | $124.87 | 3 | $0 (2021) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $99.56 | 1 | $0 (2018) |
| Lilly USA, LLC | $97.94 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $84.36 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $457.52 | 34 | PFIZER INC. ($137.85) |
| 2023 | $320.56 | 19 | Merck Sharp & Dohme LLC ($57.31) |
| 2022 | $267.05 | 18 | Boehringer Ingelheim Pharmaceuticals, Inc. ($45.39) |
| 2021 | $347.40 | 22 | Biohaven Pharmaceuticals, Inc. ($69.12) |
| 2020 | $42.18 | 3 | PFIZER INC. ($30.06) |
| 2019 | $346.44 | 14 | Amarin Pharma Inc. ($90.69) |
| 2018 | $533.88 | 26 | Merck Sharp & Dohme Corporation ($142.88) |
| 2017 | $184.64 | 5 | AbbVie, Inc. ($97.81) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 2 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Oncology | ||||||
| 02/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Obesity | ||||||
| 02/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/23/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Diabetes | ||||||
| 01/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: PAIN | ||||||
| 01/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.60 | General |
| Category: PAIN | ||||||
| 01/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: PAIN | ||||||
| 01/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Diabetes | ||||||
| 12/06/2023 | Merck Sharp & Dohme LLC | ROTATEQ (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: VACCINE | ||||||
| 09/19/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Obesity | ||||||
| 09/12/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Diabetes | ||||||
| 08/07/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Diabetes Care | ||||||
| 08/03/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Biological | ||||||
| 06/05/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Diabetes Care | ||||||
| 05/31/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Hematology | ||||||
| 05/22/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Neuroscience | ||||||
| 05/16/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/15/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/09/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.12 | General |
| Category: UROLOGY | ||||||
| 04/06/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Urology | ||||||
| 03/01/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/28/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Oncology | ||||||
| 01/31/2023 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 454 | 664 | $182,780 | $45,650 |
| 2022 | 12 | 479 | 746 | $200,583 | $50,092 |
| 2021 | 17 | 657 | 958 | $247,868 | $65,924 |
| 2020 | 16 | 536 | 817 | $231,137 | $53,063 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 262 | $87,508 | $18,787 | 21.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 93 | 93 | $31,992 | $10,904 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 107 | $23,968 | $5,955 | 24.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 86 | $19,264 | $4,933 | 25.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 24 | $10,800 | $2,306 | 21.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 19 | 19 | $4,237 | $1,191 | 28.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 13 | 13 | $2,379 | $904.16 | 38.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $1,312 | $440.40 | 33.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 13 | 14 | $280.00 | $109.20 | 39.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 14 | 14 | $560.00 | $73.32 | 13.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 16 | $480.00 | $47.74 | 9.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 134 | 278 | $92,852 | $20,598 | 22.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 80 | 80 | $27,520 | $9,654 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 131 | $29,344 | $7,715 | 26.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 97 | $21,728 | $5,303 | 24.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 36 | $15,432 | $3,125 | 20.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 16 | 21 | $4,746 | $1,345 | 28.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 19 | 19 | $4,237 | $1,053 | 24.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 27 | 29 | $2,378 | $811.12 | 34.1% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 11 | 12 | $1,056 | $314.61 | 29.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 15 | 15 | $600.00 | $92.13 | 15.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 15 | $300.00 | $44.64 | 14.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 13 | $390.00 | $37.82 | 9.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 152 | 306 | $102,289 | $25,196 | 24.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 104 | 104 | $35,776 | $13,123 | 36.7% |
About Dr. Apurva Padubidri, M.D
Dr. Apurva Padubidri, M.D is a Family Medicine healthcare provider based in Youngstown, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2014. The National Provider Identifier (NPI) number assigned to this provider is 1619397510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Apurva Padubidri, M.D has received a total of $2,500 in payments from pharmaceutical and medical device companies, with $457.52 received in 2024. These payments were reported across 141 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,500).
As a Medicare-enrolled provider, Padubidri has provided services to 2,126 Medicare beneficiaries, totaling 3,185 services with total Medicare billing of $214,728. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Youngstown, OH
- Active Since 04/18/2014
- Last Updated 01/19/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1619397510
Products in Payments
- NURTEC ODT (Drug) $164.72
- XIFAXAN (Drug) $152.70
- Vascepa (Drug) $124.87
- BELSOMRA (Drug) $118.49
- JARDIANCE (Drug) $97.85
- UBRELVY (Drug) $95.03
- Ozempic (Drug) $86.48
- SPIRIVA RESPIMAT (Drug) $84.90
- Tresiba (Drug) $66.59
- FREESTYLE LIBRE 3 (Device) $65.57
- TRELEGY ELLIPTA (Drug) $61.57
- TRADJENTA (Drug) $61.55
- JANUVIA (Drug) $61.27
- Cologuard Collection Kit (Device) $55.78
- ELIQUIS (Drug) $54.54
- VERQUVO (Drug) $51.85
- FARXIGA (Drug) $50.42
- DIFICID (Drug) $45.50
- Wegovy (Drug) $45.35
- ENTRESTO (Drug) $38.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Youngstown
Kristyn Essad, Do, DO
Family Medicine — Payments: $26,470
Dr. Russell Morrison, D.o, D.O
Family Medicine — Payments: $23,942
Dr. Joseph Gallo, Do, DO
Family Medicine — Payments: $22,278
Scott Agnew, M.d, M.D
Family Medicine — Payments: $13,472
Dr. Frank Rich, D.o, D.O
Family Medicine — Payments: $9,574
Dr. Szymon Krzyzanowski, M.d, M.D
Family Medicine — Payments: $8,272